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Abstract
An effective method for isolating common imidazole drugs clotrimazole (CT) and ketoconazole (KCZ) from cosmetic and
pharmaceutical products based on supercritical fluid extraction (SFE) was developed. Creams, tablets and cosmetic shampoos
underwent supercritical carbon dioxide fluid extraction and CT and KCZ were determined by reverse-phase high performance
liquid chromatography. All supercritical fluid extractions were performed with a 10-min static step, followed by a 15 min
dynamic step using acetonitrile as the modifier. After extraction by SFE, KCZ and CT were separated on a C18 column using an
isocratic mobile phase that consisted of methanol/water/diethylamine/glacial acetic acid (80:20:0.3:0.2, v/v, pH 7.0) at a flow rate
of 1.0 mL/min. The eluates from column were monitored by absorbance at 224 nm using a diode array detector.
This developed approach was validated by assaying commercial pharmaceuticals for the routine quantification of CT and
KCZ in various formulations. The calibration curves for CT and KCZ were linear over the ranges of 50~250 μg/mL and 25~250
μg/mL, respectively. The detection limits of CT and KCZ were 2.31 μg/mL and 0.42 μg/mL, respectively, and the limits of quantitation were 7.70 μg/mL and 1.40 μg/mL, respectively. These drugs contents were found to be in good agreement with the label
claim values. Satisfactory extraction recoveries ranging from 90.8% to 97.2% were obtained from five replicate extractions.
Key words: supercritical fluid extraction, clotrimazole (CT), ketoconazole (KCZ), imidazole drugs

Introduction
Clotrimazole (1-(α-2-chlorotrityl) imidazole, CT)
and Ketoconazole (cis-1-acet yl- 4[4 -[2-(2,4 -dichlo rophenyl)-2- (1H-imidazol-1-ylmethyl)-1,3-dioxolan4-yl]methoxyphenyl]piperazine, KCZ) (Figure 1) are
common broad-spectrum antifungal agents in commercial pharmaceutical preparations. CT, an inhibitor of
trout cytochrome P450s (1), is recognized to have neuroprotective effects (2) and can be used to treat cancer (3).
Occupational contact sensitization in CT by patch test
(5% CT in white vaseline) was reported in 1998(4). KCZ
is a potent inhibitor of P-glycoprotein and suppresses

Ketoconazole (KCZ)

Clotrimazole (CT)

Figure 1. Chemical st r uct u res of Ketoconazole (KCZ) and
Clotrimazole (CT).
* Author for correspondence. Tel: +886-4-26318652 ext. 4013;
Fax: +886-4-26319175; E-mail: hmliu@sunrise.hk.edu.tw

the oxidative activity of cytochrome P450 3A4 in the
liver. The recommended daily oral dose of KCZ should
not exceed 200 mg because of the risk of hepatoxicity(5).
KCZ is authorized for use in antidandruff shampoos
at concentrations between 1% and 2%. Therefore, the
quantity control of KCZ and CT in pharmaceuticals has
been the focus of many researches.
A number of methodologies have been proposed
for the analysis of KCZ and CT in phar maceutical
preparations or their subsequent residues in biological
f luids. These approaches include adsorptive stripping
voltammetry (6) , liquid chromatography coupled with
tandem mass spectrometry (LC-MS) (7), capillary zone
electrophoresis (CZE) (8), spectrophotometric method (9),
spectrof luorimetric method (10) and reverse-phase highperformance liquid chromatography (HPLC)(11-13), where
the HPLC method is the most widely used one. The
HPLC method is more sensitive than the CZE method
and provides a reproducible quantitation of KCZ in drug
matrices (tablets and creams) with a relative standard
deviation (R.S.D.) below 1.5% (14). The HPLC method
has limited separation efficiency for molecules with high
molecular weight (such as KCZ and CT) and this could
be improved by employing higher pressure or longer
retention time. For example, CT and its analogues were
successfully quantified by HPLC with a longer retention
time of 30 min (15). Among the published HPLC meth-
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ods, the mobile phase generally comprises salt-containing reagents, such as potassium dihydrogenphosphate (11).
T he H PLC assay for t he deter m i nat ion of KCZ i n
common pharmaceutical preparations used acetonitrile
phosphate buffer as the mobile phase (12). In this study, a
chromatographic method, where salt-containing reagents
was not used in the mobile phase, was developed for the
analysis of KCZ and CT in various drug matrices.
Becau se of t he complex it y of pha r ma ceut ical
matrix, a time-consuming sample pretreatment such as
liquid-liquid extraction(16), ultrasonic extraction(11-12) or
acid degradation(13) is inevitably required. Supercritical
fluid extraction (SFE) is a powerful sample preparation
method for isolating pharmaceutical compounds, especially the relatively non-polar components from solid
and semisolid pharmaceutical matrices (14). CT and KCZ
had been isolated from commercial pharmaceuticals
using supercritical carbon dioxide at high pressure. For
instance, Cavrini et al. isolated CT from commercial
pharmaceutical preparations using 10% (v/v) methanol
modified carbon dioxide at an extraction pressure of
380 bar (about 5510 psi)(16) where the cream sample was
premixed with celite and anhydrous sodium sulfate. A
new method that CT can be isolated from commercial
pharmaceuticals at 2000 psi without premixing celite or
the use of drying agents was approached in this study.
Here we described a sample preparation method based
on SFE for the rapid isolation of KCZ and CT from various
pharmaceutical formulations prior to the analysis by HPLC.
The application for the assay of KCZ and CT in commercial
pharmaceutical formulations was also investigated.

MATERIALS AND METHODS
I. Apparatus
SFE was perfor med using a supercr itical f luid
extractor (ISCO Model SFX 220, ISCO Inc., Lincoln,
NE) equipped with a linear coaxially restrictor heater and
a 50-µm I.D. fused-silica capillary restrictor. ISCO 260D
syringe pump was used to deliver CO2 to the extraction
unit at constant pressure. All of SFEs were performed
with 1 mL of acetonitrile as the modifier, which was
directly added to a 10-mL extraction vessel with a total
CO 2 volume of 30 mL. The extraction f low rate of
approximately 1.5 mL/min was maintained by a variable
restrictor.
HPLC analysis was conducted using a Shimadzu
LC 10AT equipped with a SIL-10AF auto injector, and an
SPD-M10A diode array detector. A Waters C18 column
(150 mm × 4.6 mm) and a Waters guard column (20 mm
× 3.9 mm) were used. Ten microliter of sample was
analyzed at a flow rate of 1.0 mL/min and monitored by
the absorbance at 224 nm. Chromatographic data acquisition and processing were carried with a Class-VP 5.0
version interface controller.

II. Reagents
Methanol and acetonitrile were of HPLC grade and
purchased from Merck (Darmstadt, Germany). KCZ and
CT were purchased from Sigma (St. Louis, MO, USA).
Acetic acid and diethylamine were of analytical grade
and also from Sigma. Deionized water was produced
using a Millipore Milli-Q apparatus (Milford, MA, USA).
Samples that contained KCZ and CT were purchased from
several pharmaceutical stores in Taichung.
III. Standard Solutions and Calibration
The stock solutions of KCZ or CT were prepared
by dissolving 100 mg of KCZ or 100 mg of CT in the
100 mL of mobile phase, respectively. The working
standard solutions of KCZ or CT were prepared by diluting the stock solution with the mobile phase in a 10-mL
volumetric f lask. The concentrations of KCZ working
standard solutions were 25, 50, 100, 150 and 200 µg/mL.
The concentrations of CT working standard solutions
were 50, 100, 150, 200 and 250 µg/mL. These drug solutions were stable for at least two months at room temperature.
IV. Sampling
Each pharmaceutical sample was weighed accurately (ca. 0.1 g) and placed in an empty 2.5-mL extraction
vessel; it was spiked with 1 mL of acetonitrile, and the
tablets were grounded using a mortar and pestle before
SFE processing. After supercritical f luid extraction,
the extract was collected in a 30-mL trap containing 10
mL of mobile phase solution at ambient temperature,
followed by filtration through a 0.45-µm Nylon-66 filter.
V. Method Validation
The developed approach was verified by the precision, accuracy, limit of detection (LOD) and limit of
quantification (LOQ). The accuracy was determined by
comparing the measured and label claim values of real
pharmaceutical samples (n = 5). The precision of the
method was evaluated from the coefficient of variation
(CV) of the five quantitative analyses. The LOD and
LOQ, expressed as signal/noise = 3 and signal/noise =
10, were determined based on standard deviation through
responses and the slope of regression equation of a curve
constructed at lower concentration levels (15, 30, 45, 60
and 75 µg/mL for CT, and 10, 20, 30, 40 and 50 µg/mL
for KCZ, respectively).
The accuracy of the proposed SFE was evaluated
as the extraction recovery, which was defined as (found
concentration/spiked concentration) × 100%. For extraction recoveries study, pharmaceutical samples spiked
with 2, 4 and 6 µg CT or KCZ standard solutions were
extracted and analysed on the same day. The concentra-
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Results and discussion
I. Optimization of SFE Method
In this study, SFE conditions were optimized using
a step-by-step design described by McNally (18). A stepby-step approach is used as an alternative to the factorial design approach (19) due to similar results with less
data processing. The effects of five parameters, namely
extraction pressure, extraction temperature, the static
extraction time, the dynamic extraction time and the
amount of modifier added (20) , on the extraction efficiency of the SFE were investigated. Besides, there are
three main extraction modes, namely static, dynamic and
static-dynamic extractions in SFE. In static extraction,
the penetration of the matrix by the fluid exceeds that in
dynamic extraction, and the extraction time is usually
less than in dynamic extraction mode. Static-dynamic
extraction is more effective than static mode extraction and the consumption of supercritical fluid is lower.
Therefore, samples are extracted in a static-dynamic
mode with CO2 throughout this study.
(I) Effect of Extraction Pressure

In this study, the optimal extraction pressure for the
SFE of KCZ cream and CT cream was 2000 psi, which
was lower than that reported by Taylor et al., which was
around 300 bar (about 4350 psi) ~500 bar (about 7250
psi) (17). Besides, CT was extracted from creams using
SFE at 2000 psi, which was lower than that reported by
Cavrini et al.(16), 380 bar (about 5510 psi). With their SFE
procedures, the time consumed for CT creams formulations was 4 min and a recovery of 100% was reported.
In other studies, pharmaceuticals were extracted by
SFE-CO 2 at 50°C at a pressure of 5800 psi for tablet
formulations, and cream formulations were extracted by
inverse SFE at 450 atm (about 6615 psi) and 60°C(17). CT
and KCZ were successfully isolated from various pharmaceuticals at extraction pressures lower than 3000 psi
in this study. In previous researches, the extraction of
tablets required higher pressure and temperature than the
extraction of creams and shampoos(21).
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tion responses were compared to those directly injected
standards with the same amounts of CT or KCZ. The
precision was evaluated by the coefficient of variation
(CV) of triple extractions.
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At first, extractions were performed at pressures
from 1500 psi to 3500 psi in a 500 psi increment at fixed
temperature (35°C) during a 10-min static extraction and
a 10-min dynamic extraction periods using supercritical carbon dioxide, to investigate the effect of extraction
pressures on the efficiency of SFE. The effects of pressure on the extraction recoveries of KCZ and CT from
shampoo and cream matrices were presented in Figure 2
(A). Regardless of extraction pressure, the recoveries of
KCZ from shampoo were in the range of 83.6% ~ 87.2%.
However, increasing the extraction pressure from 1500
psi to 2000 psi markedly boosted the extraction recoveries for both KCZ cream and CT cream. Increasing
the extraction pressure at fixed temperature increases
the density of supercritical f luid and thus enhances the
solvent strength of the supercritical f luid (18) . As the
extraction pressure increased from 2000 psi to 3500 psi,
the recoveries of the KCZ cream and CT cream were in
the range 67.4% ~ 80.9%. Hence, subsequent extractions were performed at a pressure of 2000 psi for KCZ
shampoo, KCZ cream and CT cream. It is also shown
in Figure 2(A) that the recoveries of the KCZ cream and
CT cream decreased as the extraction pressure increased
from 2000 psi to 3500 psi. It was probably because the
solubility of these analytes was considered less pressure
dependent or poor collection efficiencies (20).
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Figure 2. (A) Effect of pressures on the recoveries of KCZ and
CT from shampoo and cream formulations by SFE. (B) Effect of
pressures on the recoveries of KCZ and CT from tablets formulation
by SFE.

28
Journal of Food and Drug Analysis, Vol. 15, No. 1, 2007

Increasing the temperature at a fixed pressure usually reduces the fluid density and the extraction efficiency,
but in some cases, increases the extraction efficiency.
The effect of temperatures on the extraction efficiencies
depends on the analyte and the matrix. The effect of
temperature (35, 40, 45, 50 and 55°C) at the optimized
pressure (2000 psi) on the extraction efficiencies of KCZ
shampoo, KCZ cream and CT cream during a 10-min
static and a 10-min dynamic extraction periods using
supercritical carbon dioxide was examined. Besides, the
effect of temperature (40, 50, 60, 70, 80 and 90°C) on
the extraction efficiencies of KCZ and CT tablets under
the same condition were also investigated. As shown in
Figure 3(A), increasing the extraction temperature from
35°C to 40°C in the extraction of KCZ from shampoo
would improve recoveries from 86.8% to 96.4%. As the
temperature was increased from 40°C to 55°C, similar
extraction recoveries (94.8% ~ 91.2%) were observed.
Higher temperature did not substantially improve the
extraction recovery for KCZ shampoo. Supercritical
f luid extraction of KCZ and CT from cream formulation at 45°C resulted in the highest recoveries (97.3%
and 95.7%) in this work. Therefore, 45°C was chosen as
the optimal extraction temperature for the SFE of KCZ
and CT from both shampoo and cream formulations.
As presented in Figure 3(B), increasing the extraction
temperature of KCZ and CT from tablets dramatically
increased the recovery at 3000 psi, which reached a
maximum (89.2% and 85.8%) at 80°C. Accordingly, 80°
C was chosen as the optimal extraction temperature for
the SFE of KCZ and CT from tablet formulation.
(III) Effect of Adding a Modifier
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(II) Effect of Extraction Temperature

modifier (generally organic solvents) increases the solvent
strength of the fluid or improves the desorption of analytes
from the sample matrices, thus improving the extractability of target analytes(22). There are two modes of modifier addition, dynamic mode or static mode. On the other
hand, the modifier can be directly added into the sample
matrix in static mode. Previous researches about the
extraction of pharmaceutical formulations indicated that
the addition of the modifier to the sample matrix prior to
the extraction would improve the extraction efficiency(23).
Acetonitrile (ACN) was the best static modifier used
to spike the organic solvent tested herein. The modifier
was added directly into the 10-mL extraction vessel, with
the range of 1% ~ 10% (v/v) as described by Yamini et
al.(20). The percentage of ACN was determined by the
volume of ACN divided by the extraction vessel volume (10
mL) in static mode. The modifier was added directly into
the extraction vessel, and swept from the extraction vessel,
where the supercritical fluid started to circulate through
the sample. Therefore, the modifier would increase the
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The effect of pressure on the extraction efficiencies
of KCZ tablets and CT tablets at constant temperature
of 35°C during a 10-min static extraction and a 10-min
dynamic extraction periods using supercritical carbon
dioxide were evaluated herein. As shown in Figure 2(B),
increasing of the extraction pressure from 1500 psi to
3000 psi considerably increased the recoveries for KCZ
and CT tablets, indicating that increasing the pressure
at a fixed temperature above the critical temperature
(31.3°C) would improve the solvating power and the
density of the supercritical carbon dioxide (18). Since the
extraction recovery slightly decreased at the pressure of
3500 psi, 3000 psi was taken as the optimal pressure for
the extraction of KCZ and CT from tablet formulation.
The extraction recoveries of KCZ and CT were 89.2%
and 89.3%, respectively.
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Although carbon dioxide is the most common supercritical fluid in SFE, pharmaceutical products containing
active components are virtually insoluble in supercritical carbon dioxide fluid. Addition of a small amount of

Figure 3. (A) Effect of temperatures on the recoveries of KCZ
and CT from shampoo and cream formulations by SFE. (B) Effect
of temperatures on the recoveries of KCZ and CT from tablets
formulation by SFE.
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solubility of samples in the supercritical fluid(24).
The effects of the volume of ACN, 0 (0%), 0.1 mL
(0.1%), 0.5 mL (5%) and 1 mL (10%), on the extraction recovery were demonstrated in Figure 4. For KCZ
for mulations, when 1 mL of ACN was added in the
vessel, the extraction recoveries were 30% ~ 66% higher
than that obtained by pre-spiking with 0.5 mL of ACN;
the same result was obtained for the CT formulations.
Hence, SFE with 1 mL-acetonitrile-modified carbon
dioxide was applied throughout this study. Pre-spiking
with 1 mL of acetonitrile improved the extraction efficiency of the fluid by a “co-extraction effect”.

By 10 min-dynamic extraction, the recoveries of KCZ
from shampoo, cream and tablets were 85.2%, 86.3%
and 82.4%, and CT from cream and tablets, 87.2% and
86.9%, respectively. Increasing the dynamic extraction
time to 15 min did improve the recoveries of KCZ and CT
from shampoo, cream and tablets, ranging from 92.6%
to 101.5%. However, increasing the dynamic extraction
time to 20 min did not improve the recoveries. Therefore,
15 min was chosen as the optimal time for the dynamic
extraction of KCZ and CT from various matrices.

(IV) Effect of Extraction Time

The pH value of the mobile phase was adjusted
between 4.0 and 6.0 in most liquid chromatographic methods for analyzing KCZ(25-26). KCZ undergoes hydrolysis
in alkaline solution with a loss of peak symmetry, while
it is stable in ethanolic solution at room temperature (27).
On the other side, CT is stable in alkaline medium but
hydrolyzes into imidazole and (2-chlorophenyl)-diphenyl
methanol in acidic medium(17,28). The optimal pH value
of the mobile phase for the analysis of both CT and KCZ
tested is 7.0 in this work. The mobile phase solution with
a pH value more or less than 7.0 resulted in poor precision.
Therefore, for safe consideration, the appropriate pH of
the mobile phase for isolating CT and KCZ from admixtures was finally adjusted to 7.0 herein.
A n i mp or t a nt me r it of t h is prop ose d met ho d
compared to other chromatographic methods is that
the mobile phase was prepared without salt-containing
reagents. It substantially reduced the possibility of crystallization and column cleaning time and extended the
life of the column. The mobile phase used to separate
KCZ and CT consisted of methanol/water/diethylamine/
glacial acetic acid (80:20:0.3:0.2, v/v) in this study. The
addition of diethylamine or equivalents to the mobile
phase as a masking reagent prevented the tailing of
peaks and increased the retention time by the interaction
between basic drugs and silica gels (29).
T he c a l ib r at ion c u r ve s of KCZ a nd C T we r e
obtained by regression analyses of peak areas against
concentrations. The calibration curve was plotted over
the range of 25 ~ 250 μg/mL for KCZ with a correlation coefficient of 0.9994. The calibration curve for CT
was over the range of 50 ~ 250 μg/mL with a correlation coefficient of 0.9998. In this method, the retention
times of CT standard and CT from various matrices were
nearly the same (7.01 min, 7.01 min and 7.01 min) as
shown in Figure 5. The retention times of KCZ standard
and KCZ from various matrices were 4.96 min, 4.98 min,
5.00 min and 4.96 min, as shown in Figure 6.
The proposed methods were applied to the determination of KCZ and CT in standard and commercial pharmaceutical samples. The accuracy of the proposed SFE
approach was evaluated as the extraction recovery, which
was defined as (found concentration/spiked concentration) × 100%, and satisfactory recoveries ranging from

In previous experiments, the extraction time was
fixed at 10 min for both static and dynamic extractions
with recoveries lower than 90.0 %. In order to obtain
better recovery, three static time (10, 15, 20 min) followed
by 15 min of dynamic extraction tested at the optimized
pressure and temperature. With 10-min static extraction, the recoveries of KCZ from shampoo, cream and
tablets were 85.2%, 86.3% and 82.4%, respectively. The
recoveries of CT from cream and tablets were 87.2% and
86.9%, respectively. No significant improvement in the
extraction recoveries of KCZ and CT was observed by
longer static time (15 min or 20 min). The penetration
of the matrix by the f luid in static extraction exceeds
that in dynamic extraction, and the effect of static time
on the extraction efficiency depends on the analyte and
the matrix. Therefore, 10 min was chosen as the optimal
static extraction time for extracting KCZ and CT from
various matrices. On the other side, three dynamic times
(10, 15, 20 min) following 10 min of static extraction at
the optimal pressure and temperature were examined.
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Figure 4. Effect of modifier volume on extraction efficiency of
KCZ and CT from various pharmaceuticals. (SFE was performed
with 2000 psi at 45°C for creams and for shampoo and with 3000
psi at 80°C for tablets, respectively.).

II. Validation of the Developed Method
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90.6% to 100.1% were obtained as shown in Table 1. The
precision was evaluated by the coefficient of variation
(CV) of triple extractions. The developed SFE approach
for the analysis of CT and KCZ was validated as accurate
and precise with low CV ranging from 1.04% to 5.93%.
The accuracy and precision of this proposed methods were also evaluated by the quantitative analysis CT
or KCZ from different samples (n = 5) as shown in Table
2. KCZ was extracted from different formulations under
the optimal SFE conditions. It resulted in satisfactory
extraction efficiencies of 92.2% ~ 97.1% and CV values
of less than 2.80%. The LOD and LOQ for KCZ were
determined to be 2.31 and 7.70 μg/mL, respectively,

which were lower than that of HPLC method by Velikinac et al.(14), for which the corresponding values were
2.52 μg/mL and 6.25 μg/mL, respectively. The extraction of CT from creams and tablets under the optimal
SFE conditions resulted in satisfactory recoveries ranging from 90.8% to 97.2% from five replicate determinations and CV values of less than 3.98%. The LOD and
LOQ of CT were determined to be 0.42 μg/mL and 1.40
μg/mL, respectively in this study, and the LOD was
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Figure 5. HPLC chromatograms of CT in various pharmaceutical
formulations. Column: C18 column (150 mm × 4.6 mm); detection:
224 nm; eluent: MeOH/H 2 O/diethylamine/glacial acetic acid
(80:20:0.3:0.2, v/v); flow rate: 1.0 mL/min.

Figure 6. HPLC chromatograms of KCZ in various pharmaceutical
formulations. Column: C18 column (150 mm × 4.6 mm); detection:
224 nm; eluent: MeOH/H 2 O/diethylamine/glacial acetic acid
(80:20:0.3:0.2, v/v); flow rate: 1.0 mL/min.

Table 1. Recoveries of spiked standard solutions to pharmaceutical samplesa
Cream/KCZ

Shampoo/KCZ

Tablet/KCZ

Cream/CT

Tablet/CT

a

Spiked mass (µg)

Mass detected ± SD (µg)b

Recovery (%) ± SDb

CV (%)b

2.00

1.82 ± 0.06

90.59 ± 3.27

3.61

4.00

3.68 ± 0.05

91.76 ± 1.39

1.52

6.00

5.81 ± 0.08

96.25 ± 1.61

1.67

2.00

1.92 ± 0.03

95.37 ± 1.97

2.07

4.00

4.03 ± 0.04

100.07 ± 1.17

1.17

6.00

5.78 ± 0.19

95.83 ± 3.47

3.62

2.00

1.91 ± 0.04

95.25 ± 2.02

2.12

4.00

3.76 ± 0.07

93.92 ± 1.74

1.85

6.00

5.85 ± 0.06

97.55 ± 1.01

1.04

2.00

1.89 ± 0.08

91.57 ± 5.43

5.93

4.00

3.64 ± 0.04

90.96 ± 1.34

1.48

6.00

5.63 ± 0.18

93.75 ± 3.38

4.09

2.00

1.93 ± 0.03

96.42 ± 1.52

1.58

4.00

3.84 ± 0.11

95.98 ± 2.94

3.06

6.00

5.77 ± 0.14

96.14 ± 2.29

2.39

 FE was performed with 10% ACN modifier. SFE was performed with 2000 psi at 45°C for creams and for shampoos and with 3000 psi at
S
80°C for tablets, respectively.
b
Each value is the mean of triple extractions. The recovery was confirmed by HPLC-DAD.
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Table 2. Quantitative results of KCZ and CT in commercial pharmaceuticalsa
Extraction
efficiency (%)b

CV (%)b

0.97 ± 0.01% KCZ (w/w)

97.20 ± 1.14

1.17

2% KCZ (w/w)

1.94 ± 0.00% KCZ (w/w)

97.09 ± 0.03

0.03

2% KCZ (w/w)

1.90 ± 0.00% KCZ (w/w)

95.12 ± 0.01

0.01

19.13 ± 0.11 mg KCZ/g cream

95.65 ± 0.54

0.56

18.93 ± 0.25 mg KCZ/g cream

94.63 ± 1.26

1.33

9.13 ± 0.13 mg CT/g cream

90.75 ± 1.10

1.21

Sample

Labeled ingredient /amount

Shampoo 1

1% KCZ (w/w)

Shampoo 2
Shampoo 3
Cream 1

20 mg KCZ/g cream

Cream 2

20 mg KCZ/g cream

Cream 3

10 mg CT/g cream

Quantitative results

Cream 4

10 mg CT/g cream

9.72 ± 0.37 mg CT/g cream

97.01 ± 3.86

3.98

Tablet 5

20 mg KCZ/g tablet

18.44 ± 0.52 mg KCZ/g tablet

92.20 ± 2.58

2.80

Tablet 6

6.67 mg CT/g table

6.05 ± 0.12 mg CT/g tablet

90.77 ± 1.87

2.06

a

SFE condition was the same as Table 1. The quantitative results were confirmed by HPLC-DAD.
b
Each value is the mean of five extractions, mean ± SD.

lower than that of HPLC method by Lin and Wu (15), for
which the corresponding value was 0.5 μg/mL.

ConclusionS
The proposed method used for CT and KCZ analysis
in shampoos, creams and tablets was precise and reproducible, which provided a valuable method for the quality control of these two drugs in the studied matrices.
The effects of pressure, temperature, extraction time and
modifier concentration on the extraction efficiency of
CT and KCZ from various pharmaceutical matrices were
investigated. With the proposed HPLC method with
SFE, it is possible to detect CT and KCZ down to 0.42
μg/mL and 2.31 μg/mL, respectively. Besides, a good
agreement was obtained between experimental values
and labeled values.
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